Glycominds
Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Glycominds Information
Geographic Data
Address:
City: Lod
State: HaMerkaz
Zip:
Country: Israel
Financial Info
Stage:
series unknown
Raised Last:
$1M
Raised Total:$1M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2005 | Venture Round | 2 | $1M |
BRM Capital Millennium II Materials Technology Fund BRM Capital Millennium II Materials Technology Fund |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
